Loomis Sayles & CO L P Armata Pharmaceuticals, Inc. Transaction History
Loomis Sayles & CO L P
- $70.3 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding ARMP
# of Institutions
26Shares Held
1.42MCall Options Held
200Put Options Held
0-
Bank Of America Corp Charlotte, NC637KShares$1.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA159KShares$437,8240.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX110KShares$303,5500.01% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$275,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.9KShares$274,6920.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $99.4M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...